Comments
Roche's breast cancer drug extends survival in study
22.06.2012. | ZURICH (Reuters) - A late-stage study showed that women with an aggressive type of breast cancer lived significantly longer when treated with Roche's new breast cancer drug Perjeta, the Swiss drugmaker said on Friday....
